These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 2494246

  • 1. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Wackers FJ, Terrin ML, Kayden DS, Knatterud G, Forman S, Braunwald E, Zaret BL.
    J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
    [Abstract] [Full Text] [Related]

  • 2. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.
    Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B.
    Circulation; 1987 Apr; 75(4):817-29. PubMed ID: 3103950
    [Abstract] [Full Text] [Related]

  • 3. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
    Singh N, Mironov D, Armstrong PW, Ross AM, Langer A.
    Circulation; 1996 Apr 01; 93(7):1388-95. PubMed ID: 8641028
    [Abstract] [Full Text] [Related]

  • 4. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD, Nesković AN, Babić R, Obradović V, Bozinović L, Marinković J, Lee JC, Tan M, Thomas JD.
    Circulation; 1994 Aug 01; 90(2):800-7. PubMed ID: 8044951
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.
    Bassand JP, Cassagnes J, Machecourt J, Lusson JR, Anguenot T, Wolf JE, Maublant J, Bertrand B, Schiele F.
    Circulation; 1991 Sep 01; 84(3):1107-17. PubMed ID: 1909218
    [Abstract] [Full Text] [Related]

  • 6. Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction.
    Res JC, Simoons ML, van der Wall EE, van Eenige MJ, Vermeer F, Verheugt FW, Wijns W, Braat S, Remme WJ, Serruys PW.
    Br Heart J; 1986 Nov 01; 56(5):414-21. PubMed ID: 3539162
    [Abstract] [Full Text] [Related]

  • 7. Impact of different reperfusion modalities on ventricular function after acute myocardial infarction.
    O'Neill WW.
    Am J Cardiol; 1988 May 09; 61(14):45G-53G. PubMed ID: 2966565
    [Abstract] [Full Text] [Related]

  • 8. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.
    Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R.
    Circulation; 1991 Mar 09; 83(3):739-46. PubMed ID: 1900223
    [Abstract] [Full Text] [Related]

  • 9. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ, Lundergan CF, Hodgson JM, Nair R, Reiner JS, Greenhouse SW, Califf RM, Ross AM.
    J Am Coll Cardiol; 1996 Aug 09; 28(2):331-7. PubMed ID: 8800106
    [Abstract] [Full Text] [Related]

  • 10. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW.
    Circulation; 1998 Feb 10; 97(5):444-50. PubMed ID: 9490238
    [Abstract] [Full Text] [Related]

  • 11. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP, Skinner JS, Hawkins T, MacDermott AF, Furniss SS, Adams PC, Kesteven PJ, Reid DS.
    Br Heart J; 1995 Oct 10; 74(4):348-53. PubMed ID: 7488444
    [Abstract] [Full Text] [Related]

  • 12. Gender and acute myocardial infarction: is there a different response to thrombolysis?
    Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, Smith JO, Burton JR, McCarthy WF, Califf RM, White HD, Weaver WD, Topol EJ, Ross AM.
    J Am Coll Cardiol; 1997 Jan 10; 29(1):35-42. PubMed ID: 8996292
    [Abstract] [Full Text] [Related]

  • 13. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
    Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P.
    Circulation; 1987 Jul 10; 76(1):142-54. PubMed ID: 3109764
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, Aubry P.
    J Am Coll Cardiol; 1998 Mar 15; 31(4):776-9. PubMed ID: 9525545
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.
    Cross DB, Ashton NG, Norris RM, White HD.
    J Am Coll Cardiol; 1991 Apr 15; 17(5):1039-46. PubMed ID: 1901072
    [Abstract] [Full Text] [Related]

  • 16. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
    Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross AM.
    J Am Coll Cardiol; 1996 Dec 15; 28(7):1661-9. PubMed ID: 8962549
    [Abstract] [Full Text] [Related]

  • 17. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
    White HD, Cross DB, Elliott JM, Norris RM, Yee TW.
    Circulation; 1994 Jan 15; 89(1):61-7. PubMed ID: 8281696
    [Abstract] [Full Text] [Related]

  • 18. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
    White HD, Rivers JT, Maslowski AH, Ormiston JA, Takayama M, Hart HH, Sharpe DN, Whitlock RM, Norris RM.
    N Engl J Med; 1989 Mar 30; 320(13):817-21. PubMed ID: 2494454
    [Abstract] [Full Text] [Related]

  • 19. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM.
    Circulation; 1995 Apr 01; 91(7):1923-8. PubMed ID: 7895348
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T, Hermens WT, Lenderink T, Molhoek GP, Grollier G, Pfisterer M, Simoons ML.
    Eur Heart J; 1996 Feb 01; 17(2):237-46. PubMed ID: 8732377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.